Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001084683 | SCV000284728 | likely benign | Tuberous sclerosis 1 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000361865 | SCV000332721 | uncertain significance | not provided | 2015-07-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001023070 | SCV001184890 | likely benign | Hereditary cancer-predisposing syndrome | 2020-04-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000361865 | SCV001791077 | likely benign | not provided | 2020-06-29 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001084683 | SCV002040165 | likely benign | Tuberous sclerosis 1 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Laboratory of Molecular Epidemiology of Birth Defects, |
RCV003153524 | SCV003843607 | likely pathogenic | Ovarian cancer | 2022-01-01 | criteria provided, single submitter | clinical testing |